- Publisher's listprice EUR 213.99
-
88 752 Ft (84 526 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 17 750 Ft off)
- Discounted price 71 002 Ft (67 621 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
88 752 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 1995
- Publisher Springer New York
- Date of Publication 2 June 1995
- Number of Volumes 1 pieces, Book
- ISBN 9780387944043
- Binding Hardback
- See also 9781461269083
- No. of pages319 pages
- Size 235x155 mm
- Weight 1470 g
- Language English
- Illustrations XIX, 319 p. Illustrations, black & white 0
Categories
Long description:
Recent research suggests that adult growth hormone (GH) deficiency, whether of pathological or physiological origin, is associated with a dis tinct syndrome that includes alterations in body composition, endocrine metabolic function, immune competence, and physical and psychosocial well-being. Not surprisingly, substantial investigative effort is currently focused on validating the above hypothesis and on determining whether restoration of a normal GH-IGF-I axis in various states of adult GH deficiency is clinically useful, safe, and cost-beneficial. This book contains the proceedings from the Symposium on GHRH, GH, and IGF-I: Basic and Clinical Advances, held December 9 to 12, 1993, in San Diego, California, and sponsored by Serono Symposia USA, Inc. The conference was meant to highlight selected novel and exciting clinical research developments related to possible therapeutic uses of recombinant human GH and IGF-I, GHRH, GH releasing peptides, and related GH secretagogues. This meeting occurred only one year after a similar Serono symposium that was somewhat more oriented to novel basic science discoveries, thus attesting to the current scientific and clinical interest in this area.
MoreTable of Contents:
I. Overview of Physiology of the GHRH-Somatostatin-GH-IGF-I Axis.- 1. Physiology of the Growth Hormone Releasing Hormone-Somatostatin-Growth Hormone-Insulin-Like Growth Factor I Axis.- 2. Role of Somatostatin in the Regulation of Growth Hormone Secretion.- 3. Growth Hormone Releasing Hormone and Growth Hormone Releasing Peptides.- 4. GH Binding Protein, GH Receptors, and Domains Involved in Signal Transduction.- 5. Insulin-Like Growth Factors During Development.- II. Effects of Recombinant Human GH and/or IGF-I in Catabolic Illness.- 6. Anabolic Effects of Recombinant Human Growth Hormone and Insulin-Like Growth Factor I in Human Disease.- 7. Growth Hormone in Children with Chronic Renal Disease: Some Metabolic Considerations.- 8. Growth Hormone: The Visible Difference in Burn Care.- 9. Effects of Recombinant Human Growth Hormone on Body Composition and Metabolism in HIV-Associated Wasting.- 10. Administration of Growth Hormone as an Adjunct to Nutritional Support in Critical Illness.- 11. Strategies for the Use of Recombinant Human Growth Hormone and Insulin-Like Growth Factor I in Amyotrophic Lateral Sclerosis.- III. Contemporary Issues in Growth and Development.- 12. Contemporary Issues in Growth and Development: An Overview.- 13. Use of Recombinant IGF-I in Syndromes of GH Insensitivity.- 14. Use of Growth Hormone in Non-Growth-Hormone-Deficient Children: Physiologic, Pharmacologic, and Ethical Issues.- 15. Growth Hormone Treatment of Nonelderly Adults with GH Deficiency.- IV. Effects of rhGH and IGF-I on Intermediary and Bone Metabolism.- 16. Overview of Growth Hormone and IGF-I Effects on Intermediary Metabolism and Bone.- 17. Effects of rhGH on Glucose, Lipid, and Amino Acid Metabolism.- 18. Metabolic Effects of IGF-I: Implications for the Therapy of Diabetes Mellitus.- 19. Modulation of Responses to GH and IGF-I by Nutritional Variables.- 20. Growth Hormone Effects on the Adult Skeleton.- 21. Insulin-Like Growth Factors and Skeletal Remodeling.- V. Use of GHRH, rhGH, and rhIGF-I in Aging.- 22. Growth Hormone and Aging: A Brief Review.- 23. Potential Benefits and Risks in Treating the Hyposomatomedinemia and Hypogonadism of Elderly Men.- 24. Effects of Growth Hormone Releasing Hormone Administration in Healthy Aging Men.- 25. Effects of Recombinant Human Insulin-Like Growth Factor I in Aging.- 26. Growth Hormone and Immune Function in the Elderly.- 27. Treatment with Growth Hormone: Focus on Specificity with a View to the Future.- Author Index.
More
